Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Evaluation of a triple combination of cytokeratin 20, p53 and CD44 for improving detection of urothelial carcinoma in urine cytology specimens.

Arville B, O'Rourke E, Chung F, Amin M, Bose S.

Cytojournal. 2013 Dec 27;10:25. doi: 10.4103/1742-6413.123784. eCollection 2013.

2.

Evaluation of double immunocytochemical staining for CK20 and P53 as a potential adjunct to cytology for urothelial cancer diagnosis.

Lenos M, Katafigiotis I, Vrettou K, Papaioannou D, Malta F, Trigka EA, Sousouris S, Constantinides C, Mikou P.

Cytopathology. 2017 Apr;28(2):96-102. doi: 10.1111/cyt.12386. Epub 2016 Nov 18.

PMID:
27859848
3.

ProEx C as an adjunct marker to improve cytological detection of urothelial carcinoma in urinary specimens.

Moatamed NA, Rao JY, Alexanian S, Cobarrubias M, Levin M, Lu D, Apple SK.

Cancer Cytopathol. 2013 Jun;121(6):320-8. doi: 10.1002/cncy.21264. Epub 2013 Jan 30.

4.

Utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3-CK20/CD44s/p53) and α-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia.

Aron M, Luthringer DJ, McKenney JK, Hansel DE, Westfall DE, Parakh R, Mohanty SK, Balzer B, Amin MB.

Am J Surg Pathol. 2013 Dec;37(12):1815-23. doi: 10.1097/PAS.0000000000000114.

PMID:
24225842
5.

Does subdivision of the "atypical" urine cytology increase predictive accuracy for urothelial carcinoma?

Bostwick DG, Hossain D.

Diagn Cytopathol. 2014 Dec;42(12):1034-44. doi: 10.1002/dc.23159. Epub 2014 May 17.

PMID:
24838797
6.

Differential diagnosis of urothelial carcinoma in situ from non-neoplastic urothelia: Analysis of CK20, CD44, P53 and Ki67.

Asgari M, Nabi Maybodi M, Abolhasani M.

Med J Islam Repub Iran. 2016 Jul 18;30:400. eCollection 2016.

7.
8.

Reflex ImmunoCyt testing for the diagnosis of bladder cancer in patients with atypical urine cytology.

Odisho AY, Berry AB, Ahmad AE, Cooperberg MR, Carroll PR, Konety BR.

Eur Urol. 2013 May;63(5):936-40. doi: 10.1016/j.eururo.2012.04.019. Epub 2012 Apr 14.

9.

Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation.

Dimashkieh H, Wolff DJ, Smith TM, Houser PM, Nietert PJ, Yang J.

Cancer Cytopathol. 2013 Oct;121(10):591-7. doi: 10.1002/cncy.21327. Epub 2013 Jun 25.

11.

Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.

Blick CG, Nazir SA, Mallett S, Turney BW, Onwu NN, Roberts IS, Crew JP, Cowan NC.

BJU Int. 2012 Jul;110(1):84-94. doi: 10.1111/j.1464-410X.2011.10664.x. Epub 2011 Nov 28.

12.

Comparative evaluation of ProEx C and ImmunoCyt/uCyt assays in atypical urine cytology.

Vergara-Lluri ME, Hu E, Rao JY, Levin M, Apple SK, Moatamed NA.

Arch Pathol Lab Med. 2014 Sep;138(9):1215-22. doi: 10.5858/arpa.2013-0433-OA.

PMID:
25171704
13.
14.

Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.

Veeramachaneni R, Nordberg ML, Shi R, Herrera GA, Turbat-Herrera EA.

Diagn Cytopathol. 2003 Jun;28(6):301-7.

PMID:
12768634
15.
16.
17.

Which urine marker test provides more diagnostic value in conjunction with standard cytology- ImmunoCyt/uCyt+ or Cytokeratin 20 expression.

Soyuer I, Sofikerim M, Tokat F, Soyuer S, Ozturk F.

Diagn Pathol. 2009 Jun 26;4:20. doi: 10.1186/1746-1596-4-20.

18.

Expression of cytokeratin 20 in urine cytology smears: a potential marker for the detection of urothelial carcinoma.

Bhatia A, Dey P, Kumar Y, Gautam U, Kakkar N, Srinivasan R, Nijhawan R.

Cytopathology. 2007 Apr;18(2):84-6.

PMID:
17397492
19.

Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.

Gomella LG, Mann MJ, Cleary RC, Hubosky SG, Bagley DH, Thumar AB, McCue PA, Lallas CD, Trabulsi EJ.

Can J Urol. 2017 Feb;24(1):8620-8626.

20.

[Value of CK20 immunocytochemistry as an adjuvant to urine liquid-based cytology in detection of urothelial carcinoma].

Li M, Li HX, Guo HQ, Zhao H, Zhao LL, Ma JH, Li CL, Cao J, Pan QJ.

Zhonghua Zhong Liu Za Zhi. 2012 Sep;34(9):669-73. doi: 10.3760/cma.j.issn.0253-3766.2012.09.006. Chinese.

PMID:
23159079

Supplemental Content

Support Center